Heart failure & cardiomyopathiesGuideline or statement
Prevention of heart failure in women: an expert consensus statement on sex-specific risk factors
- Expert consensus statement
Recommendations
As issued by the authors
Pregnancy: management of hypertensive disorders in the acute and chronic setting; prevention and treatment of peripartum cardiomyopathy (PPCM)
Gynecological conditions predisposing to heart failure (HF) (Polycystic Ovary Syndrome (PCOS), endometriosis, menopausal transition): emphasis on chronic inflammation, metabolic dysfunction and the "window of opportunity" for menopausal hormone therapy (MHT)
Cardio-oncology: mitigating Cancer Therapy-Related Cardiac Dysfunction (CTRCD) in breast and gynecological cancers — female-specific cardiotoxicity profiles, subclinical detection of cardiac dysfunction, cardioprotective strategies (ACEi, beta-blockers, SGLT2 inhibitors) during cardiotoxic treatments
Lifestyle interventions such as the DASH diet and exercise-based rehabilitation highlighted as essential for maintaining cardiac reserve
Original publication
Summarised from the published abstract; every number is checked against it